A STUDY ON PRESCRIBING PATTERN OF ANTIMICROBIAL AGENTS IN THE NEONATAL INTENSIVE CARE UNIT OF A TERTIARY CARE TEACHING HOSPITAL IN PUDUCHERRY, SOUTH INDIA
Objective: This study was done to evaluate the current prescribing and usage pattern of antimicrobial agents (AMAs) in the neonatal intensive care
Methods: A prospective, hospital-based, cross-sectional study (prescription audit) was carried out between May and August 2012 in the NICU of a
Teaching Hospital. Data were collected by reviewing case records of all neonates admitted to the NICU during the study period.
Results: A total of 120 case records were reviewed and 100 were eligible to be included in the study. Out of the 100, no antimicrobial prescription
was made in 35 case records. Remaining 65 (65%) were prescribed at least one AMA. 167 AMA prescriptions were made in total and average
number of AMAs utilized per neonate was 1.670. Cefotaxime (24.6%) was the most commonly prescribed AMA followed by amoxicillin (23.4%).
Aminoglycosides (43.7%) were the commonly prescribed group of AMAs followed by penicillins (28.7) and cephalosporins (24.6%). Most of the AMAs
were prescribed to non-bacteriologically proven infections (50.5%). Among the 167 AMA prescriptions, 104 (62.28%) were made in their brand
names and 63(37.72%) were made in their generic names. Discussion and Conclusion: This study highlights current usage of AMAs in the NICU of a tertiary care teaching hospital in Puducherry. AMAs were found to be prescribed frequently without bacteriological evidence and in their brand names. This necessitates the need for motivating doctors to improve AMA prescriptions with supportive bacteriological evidence and in generic names.
Keywords: Antimicrobial agents, Neonatal intensive care unit, Generic drugs, Non-bacteriologically proven infections.
2. Yasmin S, Osrin D, Paul E, Costello A. Neonatal mortality of low-birth-weight infants in Bangladesh. Bull World Health Organ 2001;79(7):608-14.
3. World Health Report 2005: Make Every Mother and Child Count. Geneva: WHO; 2005.
4. Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why? Lancet 2005;365(9462):891-900.
5. Lawn JE, Cousens SN, Wilczynska K. Estimating the causes of four million neonatal deaths in the year 2000: Statistical annex. In: The World Health Report 2005. Geneva: WHO; 2005.
6. Bang AT, Paul VK, Reddy HM, Baitule SB. Why do neonates die in rural Gadchiroli, India? (Part I): Primary causes of death assigned by neonatologist based on prospectively observed records. J Perinatol 2005;25 Suppl 1:S29-34.
7. Niederman MS. Appropriate use of antimicrobial agents: Challenges and strategies for improvement. Crit Care Med 2003;31(2):608-16.
8. Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C, et al. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother 2006;57(3):546-50.
9. Benet LZ. Principles of prescription order writing and patients compliance instructions. In: Goodman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilmanâ€™s The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press Inc.; 1991. p. 1640.
10. Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilisation on a preterm and neonatal intensive care unit in Germany: A prospective, cohort-based analysis. Eur J Clin Pharmacol 2010;66(1):87-95.
11. Schellack N, Gous AG. Antibiotic prescribing patterns in a neonatal intensive care unit. South Afr J Epidemiol Infect 2011;26(4):267-70.
12. Chatterjee S, Mandal A, Lyle N, Mukherjee S, Singh AK. Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India. Pharmacoepidemiol Drug Saf 2007;16(10):1141-5.
13. Warrier I, Du W, Natarajan G, Salari V, Aranda J. Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol 2006;46(4):449-55.
14. Fanos V, Cuzzolin L, Atzei A, Testa M. Antibiotics and antifungals in neonatal intensive care units: A review. J Chemother 2007;19(1):5-20.
15. ESAC Year Book; 2008. Available from: http://www.esac.ua.ac.be.
16. Dimina E, Akermanis M, Dumpis U. Antibiotic consumption in latvian teaching hospital 2000-2008. Proc Latv Acad Sci 2009;63:253-6.
17. Borg AM, Zarb P. Consumption of antibiotics at St Lukeâ€™s hospital. Malta Med J 2006;18(1):33-8.
18. Brusic-Renaud J, AntunovicM, Subjagic V. The analysis of antibiotic consumption within the tertiary healthcare institution in Serbia during 10-year period (2001-2010). Int J Pharm Pharm Sci 2016;8(5):401-3.
19. Fullas F, Padomek MT, Thieman CJ, Van Gorp AE. Comparative evaluation of six extended-interval gentamicin dosing regimens in premature and full-term neonates. Am J Health Syst Pharm 2011;68(1):52-6.
20. Chattopadhyay B. Newborns and gentamicin - how much and how often? J Antimicrob Chemothe 2002;49(1):13-6.
21. Begg EJ, Vella-Brincat JW, Robertshawe B, McMurtrie MJ, Kirkpatrick CM, Darlow B. Eight yearsâ€™ experience of an extended-interval dosing protocol for gentamicin in neonates. J Antimicrob Chemothe 2009;63(5):1043-9.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.